Many of us have struggle to stay healthy during a year of Covid. As we contemplate the possibility that there may be some return to “normal” in the next several months we are wondering how we can resume a healthier lifestyle. Prolon may be part of the answer.
Several of our patients at Gateway have gained a fair amount of weight during this year of social isolation and we know that people who deal with depression are at greater risk of weight gain and that, on average, there has been more weight gain during the past year than in other years in the United States.
With this in mind we have been exploring various tools for helping people resume or establish a healthier lifestyle. One of those tools that we are very excited about is a modified fasting program called Prolon.
Unlike other fasting programs , Prolon was developed by an expert in longevity research at the University of Southern California, and it is a patented program that has been able to show significant health benefits for those who adopt it.
These benefits include:
- Weight loss
- Visceral fat reduction
- Cellular clean-up (an incredible process called autophagy)
- Help maintain metabolic health
Several of the clinicians at Gateway have tried it already and while it certainly required an effort to keep the commitment to five days of modified fasting, it is easier than a true fast.
If you are interested, talk to your clinician.
Prolon Clinical Study
Randomized controlled trial of 100 subjects, 71 completed three cycles of the ProLon® either in a randomized phase (N=39) or after being crossed over from a control diet group to the FMD group (N=32). Control subjects continued their normal diet. ProLon participants consumed the Fasting Mimicking Diet (FMD) for five consecutive days per month for three months. Measurements were performed prior to the diet (before) and during the recovery period after the 3rd cycle (after).
Min Wei; Sebastian Brandhorst et al. Fasting‐Mimicking Diet and Risk Factors for Aging, Diabetes, Cancer and Cardiovascular Disease. Science Translational Medicine February 15, 2017